In this study, we firstly determined whether the levels of BRCA1 mRNA expression as predictive and prognostic biomarker were associated with clinical outcomes in esophageal cancer patients who received cisplatin- or docetaxel-based treatments. Here, BRCA1 is linked to esophageal cancer.